Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated creatine kinase and malignancy.

C Eng1, A E Skolnick, S E Come

  • 1Harvard Medical School, Boston.

Hospital Practice (Office Ed.)
|December 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB.

ESMO gastrointestinal oncology·2026
Same author

Positioning EGFR re-treatment in modern metastatic colorectal cancer: insights from PARERE.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

ESMO open·2025
Same author

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

ESMO open·2023
Same author

An epistatic interaction between pre-natal smoke exposure and socioeconomic status has a significant impact on bronchodilator drug response in African American youth with asthma.

BioData mining·2020
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Elevated creatine kinase (CK) isoenzyme levels in the blood can indicate damage to the heart, brain, or skeletal muscles. These markers may also suggest advanced cancers with a poor outlook.

Area of Science:

  • Biochemistry
  • Oncology
  • Clinical Diagnostics

Background:

  • Creatine kinase (CK) is an enzyme crucial for cellular energy metabolism.
  • CK exists in several isoenzyme forms, primarily found in specific tissues like the heart, brain, and skeletal muscle.
  • Abnormalities in CK isoenzyme levels are recognized indicators of tissue damage.

Purpose of the Study:

  • To elucidate the diagnostic significance of serum CK isoenzyme levels.
  • To explore the association between elevated CK isoenzymes and specific tissue pathologies.
  • To investigate the potential of CK isoenzymes as prognostic markers in advanced malignancies.

Main Methods:

  • Serum samples were analyzed for creatine kinase isoenzyme concentrations.
  • Correlation analysis was performed between CK isoenzyme levels and diagnosed conditions.

Related Experiment Videos

  • Statistical evaluation of CK isoenzyme levels in cancer patients with varying prognoses.

    • Main Results:

    • Increased serum CK isoenzyme levels were observed in patients with myocardial infarction, stroke, and skeletal muscle injury.
    • A significant correlation was found between specific CK isoenzyme elevations and the affected tissue.
    • Elevated CK isoenzyme levels were associated with a poorer prognosis in patients with advanced-stage tumors.

    Conclusions:

    • Serum CK isoenzymes are valuable biomarkers for detecting damage in cardiac, neural, and muscular tissues.
    • The measurement of CK isoenzymes can aid in the diagnosis of various medical conditions.
    • CK isoenzymes may serve as important prognostic indicators in oncology, particularly for advanced tumors.